Published in Diabetes Care on October 15, 2013
Glycemic variability and oxidative stress: a link between diabetes and cardiovascular disease? Int J Mol Sci (2014) 0.90
ERK2 Mediates Metabolic Stress Response to Regulate Cell Fate. Mol Cell (2015) 0.85
The protective effect of the Mediterranean diet on endothelial resistance to GLP-1 in type 2 diabetes: a preliminary report. Cardiovasc Diabetol (2014) 0.82
Vitamin C: the known and the unknown and Goldilocks. Oral Dis (2016) 0.82
Anti-atherosclerotic effects of the glucagon-like peptide-1 (GLP-1) based therapies in patients with type 2 Diabetes Mellitus: A meta-analysis. Sci Rep (2015) 0.79
Selected activities of Citrus maxima Merr. fruits on human endothelial cells: enhancing cell migration and delaying cellular aging. Nutrients (2014) 0.76
Role of nutritional factors at the early life stages in the pathogenesis and clinical course of type 1 diabetes. Biomed Res Int (2015) 0.76
Does Glucagon-like Peptide-1 Ameliorate Oxidative Stress in Diabetes? Evidence Based on Experimental and Clinical Studies. Curr Diabetes Rev (2016) 0.75
Relationship between frequency of hypoglycemic episodes and changes in carotid atherosclerosis in insulin-treated patients with type 2 diabetes mellitus. Sci Rep (2017) 0.75
Dynamin-Related Protein 1 Mediates Low Glucose-Induced Endothelial Dysfunction in Human Arterioles. Am J Physiol Heart Circ Physiol (2016) 0.75
Lycium barbarum Polysaccharide Mediated the Antidiabetic and Antinephritic Effects in Diet-Streptozotocin-Induced Diabetic Sprague Dawley Rats via Regulation of NF-κB. Biomed Res Int (2016) 0.75
Antidiabetic and Antinephritic Activities of Aqueous Extract of Cordyceps militaris Fruit Body in Diet-Streptozotocin-Induced Diabetic Sprague Dawley Rats. Oxid Med Cell Longev (2016) 0.75
Antidiabetic activities of polysaccharides separated from Inonotus obliquus via the modulation of oxidative stress in mice with streptozotocin-induced diabetes. PLoS One (2017) 0.75
Effects of hydroalcoholic extract of Rhus coriaria seed on glucose and insulin related biomarkers, lipid profile, and hepatic enzymes in nicotinamide-streptozotocin-induced type II diabetic male mice. Res Pharm Sci (2017) 0.75
Oxidative stress and diabetic complications. Circ Res (2010) 9.37
Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease. Am J Physiol Endocrinol Metab (2004) 3.65
The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care (1985) 3.48
Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes (2003) 3.20
Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care (1994) 2.56
Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes Metab Res Rev (2008) 2.28
Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia (2001) 2.15
Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation (2005) 2.15
Effects of acute hypoglycemia on inflammatory and pro-atherothrombotic biomarkers in individuals with type 1 diabetes and healthy individuals. Diabetes Care (2010) 1.71
Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A. Arterioscler Thromb Vasc Biol (2010) 1.68
Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects. Metabolism (2009) 1.67
Is the diminished incretin effect in type 2 diabetes just an epi-phenomenon of impaired beta-cell function? Diabetes (2010) 1.39
Hypoglycemia, diabetes, and cardiovascular disease. Diabetes Technol Ther (2012) 1.30
The possible protective role of glucagon-like peptide 1 on endothelium during the meal and evidence for an "endothelial resistance" to glucagon-like peptide 1 in diabetes. Diabetes Care (2011) 1.23
Authors' perspective: What is the optimum intake of vitamin C in humans? Crit Rev Food Sci Nutr (2012) 1.20
Acute exposure to low glucose rapidly induces endothelial dysfunction and mitochondrial oxidative stress: role for AMP kinase. Arterioscler Thromb Vasc Biol (2011) 1.20
Protective effects of GLP-1 on glomerular endothelium and its inhibition by PKCβ activation in diabetes. Diabetes (2012) 1.18
Effects of incretin hormones on beta-cell mass and function, body weight, and hepatic and myocardial function. Am J Med (2010) 1.06
Glucagon-like peptide 1 reduces endothelial dysfunction, inflammation, and oxidative stress induced by both hyperglycemia and hypoglycemia in type 1 diabetes. Diabetes Care (2013) 1.03
When are type 1 diabetic patients at risk for cardiovascular disease? Curr Diab Rep (2010) 1.00
Hyperglycaemia and the vessel wall: the pathophysiological aspects on the atherosclerotic burden in patients with diabetes. Eur J Cardiovasc Prev Rehabil (2010) 1.00
Effects of GLP-1 on forearm vasodilator function and glucose disposal during hyperinsulinemia in the metabolic syndrome. Diabetes Care (2012) 0.99
Diabetic nephropathy: are there new and potentially promising therapies targeting oxygen biology? Kidney Int (2013) 0.91
Glucagon like peptide-1-induced glucose metabolism in differentiated human muscle satellite cells is attenuated by hyperglycemia. PLoS One (2012) 0.91
Potential role of non-insulin adjunct therapy in Type 1 diabetes. Diabet Med (2013) 0.89
Implementing cardiovascular risk reduction in patients with cardiovascular disease and diabetes mellitus. Am J Cardiol (2011) 0.89
Possible role of GLP-1 and its agonists in the treatment of type 1 diabetes mellitus. Curr Diab Rep (2012) 0.87
Insulin-induced hypoglycemia and stress oxidative state in healthy people. Acta Diabetol (2011) 0.79
Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction. Int J Cardiol (2012) 3.20
A burning question: does an adipokine-induced activation of the immune system mediate the effect of overnutrition on type 2 diabetes? Diabetes (2005) 2.30
Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol (2003) 2.17
Microangiopathy of large artery wall: a neglected complication of diabetes mellitus. Atherosclerosis (2013) 2.03
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. Free Radic Biol Med (2007) 1.88
The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control. Diabetes Care (2003) 1.74
RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes. Atherosclerosis (2005) 1.67
Soluble RAGE in type 2 diabetes: association with oxidative stress. Free Radic Biol Med (2007) 1.67
Identification of a pancreatic stellate cell population with properties of progenitor cells: new role for stellate cells in the pancreas. Biochem J (2009) 1.64
Peripheral venous congestion causes inflammation, neurohormonal, and endothelial cell activation. Eur Heart J (2013) 1.60
Evaluation of accessibility and use of new communication technologies in patients with type 1 diabetes mellitus. J Med Internet Res (2002) 1.39
The 24-h carbohydrate oxidation rate in a human respiratory chamber predicts ad libitum food intake. Am J Clin Nutr (2007) 1.37
Rapid insulinotropic action of low doses of bisphenol-A on mouse and human islets of Langerhans: role of estrogen receptor β. PLoS One (2012) 1.36
Receptor for advanced glycation endproducts (RAGE) and vascular inflammation: insights into the pathogenesis of macrovascular complications in diabetes. Curr Atheroscler Rep (2002) 1.30
Acute insulin response is an independent predictor of type 2 diabetes mellitus in individuals with both normal fasting and 2-h plasma glucose concentrations. Diabetes Metab Res Rev (2007) 1.11
Glucagon-like peptide 1 reduces endothelial dysfunction, inflammation, and oxidative stress induced by both hyperglycemia and hypoglycemia in type 1 diabetes. Diabetes Care (2013) 1.03
Aldose reductase and AGE-RAGE pathways: key players in myocardial ischemic injury. Ann N Y Acad Sci (2005) 0.95
Type 1 diabetes and cardiovascular disease. Cardiovasc Diabetol (2013) 0.94
Centenarians as super-controls to assess the biological relevance of genetic risk factors for common age-related diseases: a proof of principle on type 2 diabetes. Aging (Albany NY) (2013) 0.94
Silent myocardial ischemia is associated with autonomic neuropathy and other cardiovascular risk factors in type 1 and type 2 diabetic subjects, especially in those with microalbuminuria. Endocrine (2005) 0.92
Aberrant expression of posterior HOX genes in well differentiated histotypes of thyroid cancers. Int J Mol Sci (2013) 0.90
Neurogenin3 cooperates with Foxa2 to autoactivate its own expression. J Biol Chem (2013) 0.90
Circulating miR-192 and miR-193b are markers of prediabetes and are modulated by an exercise intervention. J Clin Endocrinol Metab (2014) 0.89
Insulin-treated type 2 diabetes is associated with a decreased survival in heart failure patients after cardiac resynchronization therapy. Pacing Clin Electrophysiol (2008) 0.88
Lower total fasting plasma adiponectin concentrations are associated with higher metabolic rates. J Clin Endocrinol Metab (2006) 0.86
Type 2 diabetes-associated carotid plaque burden is increased in patients with retinopathy compared to those without retinopathy. Cardiovasc Diabetol (2015) 0.86
Neuromuscular dysfunction in adult growth hormone deficiency. Clin Endocrinol (Oxf) (2003) 0.85
Association analyses of variants in the DIO2 gene with early-onset type 2 diabetes mellitus in Pima Indians. Thyroid (2011) 0.85
Prevalence of the metabolic syndrome in Spain using regional cutoff points for waist circumference: the di@bet.es study. Acta Diabetol (2013) 0.85
The effect of insulin on net lipid oxidation predicts worsening of insulin resistance and development of type 2 diabetes mellitus. Am J Physiol Endocrinol Metab (2007) 0.85
Effect of α-lipoic acid and exercise training on cardiovascular disease risk in obesity with impaired glucose tolerance. Lipids Health Dis (2011) 0.85
Islet amyloid polypeptide gene promoter polymorphisms are not associated with Type 2 diabetes or with the severity of islet amyloidosis. Biochim Biophys Acta (2005) 0.84
Glucose response to an oral glucose tolerance test predicts weight change in non-diabetic subjects. Obesity (Silver Spring) (2007) 0.84
BACE2 plays a role in the insulin receptor trafficking in pancreatic ß-cells. Am J Physiol Endocrinol Metab (2010) 0.83
Metabolomics approach for analyzing the effects of exercise in subjects with type 1 diabetes mellitus. PLoS One (2012) 0.83
Factors determining high-sensitivity C-reactive protein values in the Spanish population. Di@bet.es study. Eur J Clin Invest (2012) 0.82
Oscillating glucose and constant high glucose induce endoglin expression in endothelial cells: the role of oxidative stress. Acta Diabetol (2014) 0.81
Glucose abnormalities associated with impaired nocturnal fall in blood pressure in normotensive severely obese patients. Diabetes Res Clin Pract (2013) 0.81
Vitamin C further improves the protective effect of GLP-1 on the ischemia-reperfusion-like effect induced by hyperglycemia post-hypoglycemia in type 1 diabetes. Cardiovasc Diabetol (2013) 0.81
The Korle-Bu Hb variant in Caucasian women with type 1 diabetes: a pitfall in the assessment of diabetes control. Diabetes Care (2004) 0.81
Pseudo-enhancement does not explain the increased carotid adventitial vasa vasorum signal in diabetic patients. Atherosclerosis (2013) 0.80
Ambient temperature and prevalence of obesity in the Spanish population: The Di@bet.es study. Obesity (Silver Spring) (2014) 0.80
Involvement of ATP-sensitive potassium (K(ATP)) channels in the loss of beta-cell function induced by human islet amyloid polypeptide. J Biol Chem (2011) 0.79
Wolfram syndrome 2: a novel CISD2 mutation identified in Italian siblings. Acta Diabetol (2014) 0.79
Setting the hemoglobin A1c target in type 2 diabetes: a priori, a posteriori, or neither? Endocrine (2015) 0.79
Blood glucose pattern management in diabetes: creating order from disorder. J Diabetes Sci Technol (2013) 0.79
Self-assembling nanocomposites for protein delivery: supramolecular interactions between PEG-cholane and rh-G-CSF. J Control Release (2012) 0.78
Circulating SFRP5 levels are elevated in drug-naïve recently diagnosed type 2 diabetic patients as compared with prediabetic subjects and controls. Diabetes Metab Res Rev (2014) 0.77
Is there a relationship between factor V Leiden and type 2 diabetes? J Transl Med (2009) 0.77
Features and outcome of pregnancies complicated by impaired glucose tolerance and gestational diabetes diagnosed using different criteria in a Spanish population. Diabetes Res Clin Pract (2005) 0.77
Nutritional imbalances linking cellular senescence and type 2 diabetes mellitus. Curr Opin Clin Nutr Metab Care (2014) 0.77
Renal function impairment predicts mortality in patients with chronic heart failure treated with resynchronization therapy. Cardiol J (2015) 0.77
Blood pressure status and the incidence of diabetic kidney disease in patients with hypertension and type 2 diabetes. J Hypertens (2016) 0.76
Cardiovascular guidelines: separate career may help attenuate controversy. Cardiovasc Diabetol (2014) 0.76
Gastric inhibitory polypeptide receptor methylation in newly diagnosed, drug-naïve patients with type 2 diabetes: a case-control study. PLoS One (2013) 0.76
Factors affecting levels of urinary albumin excretion in the general population of Spain: the Di@bet.es study. Clin Sci (Lond) (2013) 0.76
Modifications of the homeostasis model assessment of insulin resistance index with age. Acta Diabetol (2014) 0.76
Placental expression of CD100, CD72 and CD45 is dysregulated in human miscarriage. PLoS One (2012) 0.76
Prospective study of individualized or high fixed doses of vitamin D supplementation after bariatric surgery. Obes Surg (2015) 0.76
Photodynamic topical antimicrobial therapy for infected foot ulcers in patients with diabetes: a randomized, double-blind, placebo-controlled study--the D.A.N.T.E (Diabetic ulcer Antimicrobial New Topical treatment Evaluation) study. Acta Diabetol (2013) 0.75
Safety of cabergoline in the management of pituitary prolactin-induced symptoms with patients treated with atypical neuroleptics. Curr Drug Saf (2012) 0.75
Glycated albumin: correlation to HbA1c and preliminary reference interval evaluation. Clin Chem Lab Med (2016) 0.75
[Gender differences of at risk patients with overt heart failure in the real world of general practice. Data from the GIPSI (Gestione Integrata Progetto Scompenso in Italia) registry]. G Ital Cardiol (Rome) (2010) 0.75
Haptoglobin genotype and risk of diabetic nephropathy in patients with type 1 diabetes mellitus: a study on a Spanish population. Nefrologia (2014) 0.75
The HFE gene is associated to an earlier age of onset and to the presence of diabetic nephropathy in diabetes mellitus type 2. Endocrine (2004) 0.75
Human Serum Versus Human Serum Albumin Supplementation in Human Islet Pretransplantation Culture: In Vitro and In Vivo Assessment. Cell Transplant (2015) 0.75
Anthropometric indexes outperform bioelectrical impedance analysis-derived estimates of body composition in identification of metabolic abnormalities in morbid obesity. Surg Obes Relat Dis (2012) 0.75
Plasma homocysteine is not increased in microalbuminuric patients with type 2 diabetes without clinical cardiovascular disease. Diabetes Care (2002) 0.75